Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
GraphTx
Graph Therapeutics develops targeted therapies and biomarkers for immune-driven diseases by combining perturbation modeling of primary patient cell samples with multi-omics data. The company…
GraphTx
Graph Therapeutics develops targeted therapies and biomarkers for immune-driven diseases by combining perturbation modeling of primary patient cell samples with multi-omics data. The company…
TL;DR
Sector: Precision immunology / Biotech
Founded: 2024
Stage: Pre-seed
Recent raise: $3.1M pre-seed (announced Jan 9, 2025)
Headcount (reported): 16
Company Overview
Problem Domain
Immune-driven diseases; discovery of targeted therapies and companion diagnostics using patient-derived multi-omics and perturbation data.
Founded
2024
Industry
Biotechnology
Tech Stack
Funding Track Record
$3.1M
Round included participation from NAVEC Investment Management and strategic angel investors including Mehdi Ghissassi.
Investor Signal
“Led by Squareone and Merantix Capital with participation from NAVEC Investment Management and angel investors (including Mehdi Ghissassi)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |